| Literature DB >> 33637425 |
Laxman Pandey1, Rajesh Pasricha2, Deepa Joseph1, Rachit Ahuja1, Yanpothung Yanthan1, Pankaj Kumar Garg3, Manoj Gupta1.
Abstract
BACKGROUND: The use of complementary and alternative medicine (CAM) is widespread among cancer patients in India.Entities:
Keywords: Ayurveda; CAM; Cancer; Sub-Himalayan; Uttarakhand; Yoga
Year: 2021 PMID: 33637425 PMCID: PMC8039360 DOI: 10.1016/j.jaim.2021.01.001
Source DB: PubMed Journal: J Ayurveda Integr Med ISSN: 0975-9476
Demographics of CAM users.
| Variables | Total CAM users |
|---|---|
| Male | 649 (54.5) |
| Female | 541 (45.5) |
| <50 | 538 (45.2) |
| >50 | 652 (54.8) |
| Unmarried | 119 (10.0) |
| Married | 1071 (90.0) |
| None | 607 (51.0) |
| Up to Secondary | 440 (36.9) |
| University | 143 (12.0) |
| <10,000 | 809 (67.9) |
| >10,000 | 381 (32.0) |
| Hindu | 859 (72.2) |
| Others | 331 (27.8) |
| Breast | 274 (23.0) |
| Prostate | 238 (20.0) |
| Head and Neck | 190 (15.9) |
| Urinary Bladder | 95 (7.9) |
| Others | 393 (33.0) |
| Early | 84 (7.1) |
| Advanced | 202 (16.9) |
| Metastatic/recurrent | 904 (75.9) |
Data is presented as n%. CAM, complementary and alternative medicine.
Fig. 1Schematic diagram showing common forms of CAM usages among cancer patients of sub-Himalayan state in India.
Pattern of CAM usage.
| Variables | Total |
|---|---|
| Ayurveda | 428 (35.9) |
| Yoga/Naturopathy | 381 (32.0) |
| Homeopathy | 143 (12.0) |
| Unani | 71 (5.9) |
| Others (e.g. spiritual) | 167 (14.0) |
| Trust in CAM | 488 (41.0) |
| Lack of awareness | 298 (25.0) |
| Distrust on modern medicines | 250 (21.0) |
| Fear of conventional treatment | 119 (10.0) |
| Lack of access | 35 (3) |
| Friends and Family | 809 (67.9) |
| Self-awareness from previous experience | 250 (21.0) |
| Media and Others | 131 (11.0) |
| <6 months | 393 (33.0) |
| >6 months | 797 (66.9) |
| Alternative medicine | 1012 (85.0) |
| Complementary medicine | 178 (14.9) |
| Daily/regularly | 1083 (91.0) |
| Occasionally | 83 (6.9) |
| Once | 24 (2.0) |
| Benefitted | 702 (58.9) |
| Not benefitted | 488 (41.0) |
| Progression of symptom | 762 (64.0) |
| Side effects | 107 (8.9) |
| Cost | 35 (2.9) |
| Others | 286 (24.0) |
Data is presented as n%.